Measurement of perfusion rate in human melanoma xenografts by contrast- enhanced magnetic resonance imaging

Magnetic Resonance in Medicine

Volumn 40, Issue 1, 1998, Pages 89-98

  Lyng, Heidi ^a   Dahle, Gro A ^a   Kaalhus, Olav ^a   Skretting, Arne ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Contrast enhanced MRI; Kety equation; Melanoma xenograft; Perfusion rate

Indexed keywords

DECAY (ORGANIC); DERMATOLOGY; KINETICS; MAGNETIC RESONANCE IMAGING; ONCOLOGY; TUMORS;

CONTRAST-ENHANCED; EXTRACELLULAR VOLUMES; KETY EQUATION; MELANOMA XENOGRAFTS; PERFUSION RATE; RELIABLE ESTIMATES; RELIABLE METHODS; SIGNAL INTENSITIES;

PARAMETER ESTIMATION;

GADOLINIUM PENTETATE; IODOPHENAZONE C 14; RUBIDIUM 86;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; DRUG BLOOD LEVEL; DRUG UPTAKE; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MELANOMA; MOUSE; NONHUMAN; NUDE MOUSE; PERFUSION; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR XENOGRAFT;

EID: 0031814383     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910400113     Document Type: Article

References (34)

1. R. K. Jain, Determinants of tumor blood flow: a review. Cancer Res. 48, 2641-2658 (1988).
2. P. Vaupel, F. Kallinowski, P. Okunieff, Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49, 6449-6465 (1989).
3. K. M. Donahue, D. Burstein, W. J. Manning, M. L. Gray, Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn. Reson. Med. 32, 66-76 (1994).
4. K. Fujii, N. Fujita, N. Hirabuki, T. Hashimoto, T. Miura, T. Kozuka, Neuromas and meningiomas: evaluation of early enhancement with dynamic MR imaging. Am. J. Neuro. Radiol. 13, 1215-1220 (1992).
5. H. J. Feldmann, K. Sievers, J. Füller, M. Molls, E. Löhr, Evaluation of tumor blood perfusion by dynamic MRI and CT in patients undergoing thermoradiotherapy. Eur. J. Radiol. 16, 224-229 (1993).
6. T. Nägele, D. Petersen, U. Klose, W. Grodd, H. Opitz, E. Gut, J. Martos, K. Voigt, Dynamic contrast enhancement of intracranial tumors with snapshot FLASH MR imaging. Am. J. Neuro. Radiol. 14, 89-98 (1993).
7. S. S. Kety, Theory of blood-tissue exchange and its application to measurement of blood flow. Meth. Med. Res. 8, 223-227 (1960).
8. C. A. Belfi, L.-L. Ting, S. J. Hassenbusch, M. Tefft, F. Q. H. Ngo, Determination of changes in tumor blood perfusion after hydralazine treatment by dynamic paramagnetic-enhanced magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys. 22, 477-482 (1992).
9. F. Goda, G. Bacic, J. A. O'Hara, B. Gallez, H. M. Swartz, J. F. Dunn, The relationship between partial pressure of oxygen and perfusion in two murine tumors after x-ray irradiation: a combined gadopentetate dimeglumine dynamic magnetic resonance imaging and in vivo electron paramagnetic resonance oximetry study. Cancer Res. 56, 3344-3349 (1996).
10. M.-Y. Su, Z. Wang, G. M. Roth, X. Lao, M. K. Samoszuk, O. Nalcioglu, Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA enhanced MRI. Magn. Reson. Med. 36, 868-877 (1996).
11. K. Hittmair, G. Gomiscek, K. Langenberger, M. Recht, H. Imhof, J. Kramer, Method for quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn. Reson. Med. 31, 567-571 (1994).
12. E. K. Rofstad, Orthotopic human melanoma xenograft model systems for studies of tumor angiogenesis, pathophysiology, treatment sensitivity, and metastatic pattern. Br. J. Cancer 70, 804-812 (1994).
13. L. K. Appelgren, Methods of recording tumor blood flow, in "Tumor Blood Circulation: Angiogenesis, Vascular Morphology and Blood Flow of Experimental and Human Tumors" (H.-I. Peterson, Ed.), pp. 87-101, CRC Press, Inc., Boca Raton, FL. 1979.
14. 86Rb. Cancer Res. 34, 1451-1456 (1974).
15. H. Lyng, A. Skretting, E. K. Rofstad, Blood flow in six human melanoma xenograft lines with different growth characteristics. Cancer Res. 52, 584-592 (1992).
16. G. M. Tozer, K. M. Shaffi, Modification of tumor blood flow using the hypertensive agent, angiotensin II. Br. J. Cancer 67, 981-988 (1993).
17. H. M. Kaplan, N. R. Brewer, W. H. Blair, Physiology, in "The Mouse in Biomedical Research" (H. L. Foster, J. D. Small, J. G. Fox, Eds.), pp. 247-292, Academic Press, New York, 1983.
18. E. K. Rofstad, E. Steinsland, O. Kaalhus, Y. B. Chang, B. Hevik, H. Lyng, Magnetic resonance imaging of human melanoma xenografts in vivo: proton spin-lattice and spin-spin relaxation times versus fractional tumor water content and fraction of necrotic tumor tissue. Int. J. Radiat. Biol. 65, 387-402 (1994).
19. H.-J. Weinmann, R. C. Brasch, W.-R. Press, G. E. Wesbey, Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am. J. Roentgenol. 142, 619-624 (1984).
20. E. M. Haacke, J. A. Tkach, Fast MR imaging: techniques and clinical applications. Am. J. Roentgenol. 155, 951-964 (1990).
21. L. D. Diesbourg, F. S. Prato, G. Wisenberg, D. J. Drost, T. P. Marshall, S. E. Carroll, B. O'Neill, Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn. Reson. Med. 23, 239-253 (1992).
22. L. Axel, Blood flow effects in magnetic resonance imaging. Am. J. Roentgenol. 143, 1157-1166 (1984).
23. C. Crone, D. G. Levitt, Capillary permeability to small solutes, in "Handbook of Physiology," Vol. 4 (E. M. Renkin, C. C. Michel, Eds.), pp. 411-466, American Physiology Society, Bethesda, MD, 1984.
24. J. A. Johnson, T. A. Wilson, A model for capillary exchange. Am. J. Physiol. 210, 1299-1303 (1966).
25. 14C]antipyrine. Am. J. Physiol. 229, 215-221 (1975).
26. I. Kjartansson, Tumor circulation. An experimental study in the rat with a comparison of different methods for estimation of tumor blood flow. Acta Chir. Scand. (Suppl.) 471, 1-74 (1976).
27. K. M. Donahue, R. M. Weisskoff, D. J. Parmelee, R. J. Callahan, R. A. Wilkinson, J. B. Mandeville, B. R. Rosen, Dynamic Gd-DTPA enhanced MRI measurement of tissue cell volume fraction. Magn. Reson. Med. 34, 423-432 (1995).
28. 15O. I. Theory and error analysis. J. Nucl. Med. 24, 782-789 (1983).
29. D. Burstein, E. Taratuta, W. J. Manning, Factors in myocardial "perfusion" imaging with ultrafast MRI and Gd-DTPA administration. Magn. Reson. Med. 20, 299-305 (1991).
30. 1-weighted gadolinium-DTPA enhanced MR imaging. Magn. Reson. Med. 17, 460-469 (1991).
31. F. P. van Rugge, J. J. Boreel, E. E. van der Waal, P. R. M. van Dijkman, A. van der Laarse, J. Doornbos, A. de Roos, J. A. den Boer, A. V. G. Bruschke, A. E. van Voorthuisen, Cardiac first-pass and myocardial perfusion in normal subjects assessed by subsecond Gd-DTPA enhanced MR imaging. J. Comput. Assist. Tomogr. 15, 959-965 (1991).
32. N. Wilke, G. Simm, J. Zhang, J. Ellerman, X. Ya, H. Merkle, G. Path, H. Lüdemann, R. J. Bache, K. Uǧurbil, Contrast-enhanced first-pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn. Reson. Med. 29, 485-497 (1993).
33. W. H. Perman, M. H. Gado, K. B. Larson, J. S. Perlmutter, Simultaneous MR acquisition of arterial and brain signal time curves. Magn. Reson. Med. 28, 74-83 (1992).
34. H. Köstler, H. Becker, The value of gating and flow compensation for measurements of the arterial input function in dynamic susceptibility contrast MRI. Magn. Reson. Mater. Phys. Biol. Med. (Suppl.)4, 68 (1996).